Prosight Management, LP - 24 Nov 2025 SCHEDULE 13G Report for OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR)

Filing Manager
Prosight Management, LP
Reporting Manager
Prosight Management, LP
Security
OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share
Symbol
OKUR
Shares outstanding
12,856,017 shares
Disclosed Ownership
745,649 shares
Ownership
5.8%
Form type
SCHEDULE 13G
Filing time
28 Nov 2025, 08:15:23 UTC
Date of event
24 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Prosight Management, LP disclosed 5.8% ownership in OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR) on 24 Nov 2025."

Quick Takeaways

  • Prosight Management, LP filed SCHEDULE 13G for OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR).
  • Disclosed ownership: 5.8%.
  • Date of event: 24 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 28 Nov 2025, 08:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Prosight Management, LP 5.8% 745,649 0 745,649 Prosight Partners, LLC General Partner
Prosight Fund, LP 0.3% 35,514 0 35,514 Prosight Management, LP General Partner
Prosight Plus Fund, LP 1.3% 163,487 0 163,487 Prosight Management, LP General Partner
Prosight Partners, LLC 5.8% 745,649 0 745,649 /s/ W. Lawrence Hawkins Sole Manager
W. Lawrence Hawkins 5.8% 745,649 0 745,649 /s/ W. Lawrence Hawkins W. Lawrence Hawkins

Sponsored